Skip to content

The incidence and pattern of Clostridium difficile infection (CDI) at Dunedin Hospital: A retrospective audit study.

The rate and pattern of Clostridium difficile infection (CDI) at Dunedin Hospital following the introduction of the PCR toxin gene test: A retrospective audit study.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12618001713280
Enrollment
150
Registered
2018-10-17
Start date
2018-11-01
Completion date
2019-01-01
Last updated
2018-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Clostridium difficile infection (CDI) is a major hospital-acquired infection capable of causing complications ranging from diarrhoea to severe infection. Two years ago Dunedin Hospital, which historically has low rates of CDI, introduced a PCR test which identifies the genes which produce the CD toxin. We also perform an immunoassay test to directly identify the toxin. We aim to assess the impact of this new test on the incidence of diagnosis of CDI, and to assess the clinical significance of the combined result of a PCR gene positive test and an immunoassay toxin negative test.

Interventions

Clostridium difficile infection (CDI) is a major hospital-acquired infection capable of causing complications ranging from diarrhoea to severe infection. In 2016 Dunedin Hospital, which historically has low rates of CDI, introduced a PCR test which identifies the genes which produce the CD toxin. We also perform an immunoassay test to directly identify the toxin. We aim to assess the impact of this new test on the incidence of diagnosis of CDI, and to assess the clinical significance of the comb

Clostridium difficile infection (CDI) is a major hospital-acquired infection capable of causing complications ranging from diarrhoea to severe infection. In 2016 Dunedin Hospital, which historically has low rates of CDI, introduced a PCR test which identifies the genes which produce the CD toxin. We also perform an immunoassay test to directly identify the toxin. We aim to assess the impact of this new test on the incidence of diagnosis of CDI, and to assess the clinical significance of the combined result of a PCR gene positive test and an immunoassay toxin negative test. This will be done using hospital records for the period from 2014-2018.

Sponsors

Dunedin School of Medicine, University of Otago
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients who have had a diagnosis of a Clostridium difficile infection at Dunedin Hospital from 2014-2018

Exclusion criteria

not applicable

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026